Humacyte Inc (HUMA)
4.40
+0.01
(+0.23%)
USD |
NASDAQ |
May 02, 16:00
4.40
0.00 (0.00%)
After-Hours: 16:45
Humacyte Price: 4.40 for May 2, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 01, 2024 | 3.95 | 4.565 | 3.93 | 4.39 | 2.292M |
| Apr 30, 2024 | 4.05 | 4.103 | 3.86 | 3.92 | 952284.0 |
| Apr 29, 2024 | 4.06 | 4.21 | 3.93 | 4.09 | 1.264M |
| Apr 26, 2024 | 3.92 | 4.01 | 3.85 | 3.99 | 689524.0 |
| Apr 25, 2024 | 3.79 | 3.920 | 3.71 | 3.90 | 791382.0 |
| Apr 24, 2024 | 3.95 | 4.03 | 3.695 | 3.82 | 1.509M |
| Apr 23, 2024 | 3.85 | 4.185 | 3.75 | 3.93 | 2.156M |
| Apr 22, 2024 | 3.90 | 3.90 | 3.30 | 3.70 | 2.620M |
| Apr 19, 2024 | 3.75 | 4.11 | 3.55 | 3.70 | 4.898M |
| Apr 18, 2024 | 3.18 | 3.75 | 3.17 | 3.59 | 5.795M |
| Apr 17, 2024 | 3.17 | 3.20 | 3.10 | 3.12 | 1.081M |
| Apr 16, 2024 | 3.00 | 3.117 | 2.90 | 3.06 | 1.437M |
| Apr 15, 2024 | 2.96 | 2.975 | 2.86 | 2.87 | 746920.0 |
| Apr 12, 2024 | 3.03 | 3.06 | 2.81 | 2.88 | 1.449M |
| Apr 11, 2024 | 3.04 | 3.04 | 2.92 | 3.02 | 1.692M |
| Apr 10, 2024 | 3.02 | 3.07 | 2.90 | 2.99 | 1.282M |
| Apr 09, 2024 | 3.12 | 3.165 | 3.04 | 3.04 | 1.118M |
| Apr 08, 2024 | 3.04 | 3.125 | 3.04 | 3.10 | 605021.0 |
| Apr 05, 2024 | 3.16 | 3.16 | 2.98 | 3.04 | 643307.0 |
| Apr 04, 2024 | 3.07 | 3.37 | 3.07 | 3.12 | 1.304M |
| Apr 03, 2024 | 2.92 | 3.08 | 2.89 | 3.03 | 1.137M |
| Apr 02, 2024 | 2.99 | 3.00 | 2.90 | 2.97 | 964107.0 |
| Apr 01, 2024 | 3.12 | 3.12 | 3.00 | 3.01 | 1.144M |
| Mar 28, 2024 | 3.10 | 3.14 | 3.06 | 3.11 | 964004.0 |
| Mar 27, 2024 | 3.15 | 3.25 | 3.07 | 3.10 | 1.844M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.99
Minimum
Nov 01 2023
16.99
Maximum
Sep 01 2021
5.928
Average
4.16
Median
Price Benchmarks
| Adial Pharmaceuticals Inc | 1.78 |
| Gritstone Bio Inc | 0.8602 |
| Precision BioSciences Inc | 10.63 |
| Puma Biotechnology Inc | 4.96 |
| Revance Therapeutics Inc | 3.775 |
Price Related Metrics
| Price to Book Value | 38.68 |
| Earnings Yield | -24.32% |
| Market Cap | 523.97M |